Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

S&P/ASX 200 To Open Higher, 3 ASX Shares To Watch

The S&P/ASX 200 (INDEXASX:XJO)(^AXJO) is expected to open higher today, the USA’s S&P 500 Index (.INX) went up 0.13% on Thursday.
ASX News

The S&P/ASX 200 (INDEXASX: XJO)(^AXJO) is expected to open higher today, the USA’s S&P 500 Index (.INX) went up 0.13% on Thursday.

Australian Dollar ($A) (AUDUSD): 70.93US cents

Dow Jones (DJI): down 0.09%

Oil (WTI): $US53.16 per barrel

Gold: $US1,281 per ounce

ASX Sharemarket News

In ASX sharemarket news, AMP Limited (ASX: AMP) has provided an update ahead of its FY18 results about its profits and results.

AMP is still finalising its results, but it expects to report profit attributable to shareholders of approximately $30 million, whilst ‘underlying’ profit will be $680 million.

Total business unit operating earnings in the second half are expected to be around $220 million, which is $325 million from retained businesses and a net operating loss of $105 million from businesses being sold.

The AMP Board is likely to declare a dividend of 4 cents per share, a cut of 10.5 cents per share compared to the 14.5 cents per share payment a year ago.

[ls_content_block id=”15758″ para=”paragraphs”]

Lithium business Pilbara Minerals Ltd (ASX: PLS) has reported how its December 2018 quarter went.

It said that it achieved its first shipment of 8,800wmt of spodumene concentrate from the Pilgangoora Lithium-Tantalum Project, which it boasted of going from first drill hole to production in under four years.

The company had quarterly sales of 46,682dmt and a “strong” production ramp up with a quarterly total of 47,859dmt and 56,634lbs of tantalite concentrate.

Pilbara is considering the stage 3 expansion of 6.2Mt per annum to 7.5Mt per annum. It also has a non-binding agreement with POSCO for a larger chemical conversion facility of 40kt per annum.

Read more:

Why Woodside Petroleum (WPL) Is My Favourite ASX Share

Will The Flight Travel Centre Travel Group (ASX:FLT) Share Price Fly Higher?

Can We Keep Milking A2 Milk Company (A2M) Shares?

NAB (ASX:NAB) Raises Home Loan Interest Rates – Is It A Buy?

Medicinal marijuana business Auscann Group Holdings Ltd (ASX: AC8) has completed the acquisition of a R&D facility in Perth, Western Australia to develop its product pipeline. It cost $5.25 million, which was funded from cash reserves.

[ls_content_block id=”14948″ para=”paragraphs”]

Skip to content